Table of Contents Table of Contents
Previous Page  285 / 1851 Next Page
Information
Show Menu
Previous Page 285 / 1851 Next Page
Page Background

New drugs

Taxanes: Taxol, Taxoter

Oxaliplatine

Targeted therapies

EGFR inhibitors (cetuximab, panitunimab)

Anti-angiogenic drugs

HER2 inhibitors (for Her2 ADK tumours)